icon-folder.gif   Conference Reports for NATAP  
 
  64rd Annual Meeting of the
American Association for the
Study of Liver Diseases
Washington, DC Nov 1-5 2013
Back grey_arrow_rt.gif
 
 
 
Resistance analyses of HCV isolates from patients treated with simeprevir in Phase IIB/III studies
 
 
  Reported by Jules Levin
AASLD 2013 Nov 1-4 Wash DC
 
Oliver Lenz,1 Bart Fevery,1 Thierry Verbinnen,1 Lotke Tambuyzer,1 Leen Vijgen,1 Monika Peeters,1 Maria Beumont-Mauviel,1 Gaston Picchio,2 Sandra De Meyer1 1Janssen Infectious Diseases BVBA, Beerse, Belgium; 2Janssen Research & Development, LLC, Titusville, NJ, USA

AASLD1.gif

AASLD2.gif

AASLD3.gif

AASLD4.gif

AASLD5.gif

AASLD6.gif

AASLD7.gif